Showing results (431-440 of 658) with videos related to
Sort By:
Pageof 66
Annals of Internal Medicine|July 5, 2022
Antinucleocapsid Antibodies After SARS-CoV-2 Infection in the Blinded Phase of the Randomized, Placebo-Controlled mRNA-1273 COVID-19 Vaccine Efficacy Clinical TrialDean Follmann, Holly E Janes, Olive D Buhule, et al.Lancet (London, England)|June 24, 2008
Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trialConnie Celum, Anna Wald, James Hughes, et al.Journal of the International AIDS Society|June 26, 2023
Counterfactual estimation of efficacy against placebo for novel PrEP agents using external trial data: example of injectable cabotegravir and oral PrEP in womenDeborah Donnell, Fei Gao, James P Hughes, et al.Blood|April 4, 2002
A humanized non-FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host diseasePaul A Carpenter, Frederick R Appelbaum, Lawrence Corey, et al.Nature Biotechnology|November 20, 2018
T cell receptor fingerprinting enables in-depth characterization of the interactions governing recognition of peptide-MHC complexesAmalie K Bentzen, Lina Such, Kamilla K Jensen, et al.Nature Communications|November 14, 2022
Selective retention of virus-specific tissue-resident T cells in healed skin after recovery from herpes zosterKerry J Laing, Werner J D Ouwendijk, Victoria L Campbell, et al.Immunohorizons|August 6, 2020
Proteome-Wide Zika Virus CD4 T Cell Epitope and HLA Restriction DeterminationVictoria L Campbell, LeAnn Nguyen, Elise Snoey, et al.The Journal of Infectious Diseases|April 3, 2007
Topical resiquimod 0.01% gel decreases herpes simplex virus type 2 genital shedding: a randomized, controlled trialKaren E Mark, Lawrence Corey, Tze-Chiang Meng, et al.Scientific Reports|March 14, 2017
Worldwide circulation of HSV-2 × HSV-1 recombinant strainsDavid M Koelle, Peter Norberg, Matthew P Fitzgibbon, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 27, 2016
Extensive CD4 and CD8 T Cell Cross-Reactivity between AlphaherpesvirusesLichen Jing, Kerry J Laing, Lichun Dong, et al.Pageof 66